Higher Expression of EpCAM Is Associated With Poor Clinical and Pathological Responses in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Pathology International - United Kingdom
doi 10.1111/pin.12404
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Wiley